MITRE Announces “Compass”, a tool to collect “mCODE” Oncology Data, at HIMSS-19

Big Data News

MITRE-Announces-Compass-a-tool-to-collect-mCODE-Oncology-Data-at-HIMSS-19 MITRE Announces “Compass”, a tool to collect “mCODE" Oncology Data, at HIMSS-19MITRE, a Bedford, Massachusetts, and McLean, Virginia-based not-for-profit organization, on Monday, Feb. 11th 2019, revealed the “Compass”, an open-source application to collect minimal common oncology data elements (mCODE), from electronic health records (EHRs), at the Healthcare Information and Management Systems Society  (HIMSS) 2019 Global Conference, that took place from Monday, Feb.11th 2019 – Friday, Feb. 15th 2019, at the Orange County Convention Center, Orlando, Florida.

As per reports, only three percent of adult cancer patients participate in clinical trials, this greatly limits access to high-quality cancer data across multiple types of cancers. With mCODE data standards (currently under development) breakthrough insights into high-quality data for multiple cancer use cases will be possible. According to Dr. Brian Anderson, chief clinical lead at MITRE, advancements in cancer care and research are being driven by high-quality, sharable data. mCODE with its standardized set of cancer data points within health records will enable Compass to extract that data, organize, and inform doctors, patients, and researchers.

Compass, being a SMART (substitutable medical applications and reusable technologies) on FHIR (fast healthcare interoperability resources) application, extracts mCODE data elements from EHRs, organizes it and delivers reports to providers and patients, this ensures better and improved diagnosis and patient care planning.

ASCO, the American Society of Clinical Oncology, will be leading the development of the mCODE data standard, working with MITRE and other stakeholders, to improve data and records interoperability in oncology care and research.